Janux Therapeutics · 1 day ago
Senior Scientist, Protein Engineering (Phage Display)
Janux Therapeutics is seeking a highly skilled Senior Scientist in Protein Engineering to advance our innovative discovery programs. This role requires hands-on expertise with phage display platforms and antibody discovery and optimization techniques, and involves working independently and collaboratively in a fast-paced biotech environment.
BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Design, construct, and quality check phage display libraries used in peptide and antibody-based screening campaigns targeting diverse antigens
Screen synthetic and immune phage libraries for high-affinity binders
Characterize peptide and antibody candidates using biochemical, biophysical, and cell-based assays (e.g., ELISA, BLI, flow cytometry)
Develop directed evolution libraries and execute screening methods to optimize peptide and antibody formats for improved affinity, stability, and developability
Collaborate with protein sciences and protein engineering teams to produce and validate peptide and antibody candidates
Analyze sequencing data from phage pools and selected clones to identify lead candidates
Maintain accurate and detailed experimental records and present findings in internal meetings
Contribute to patent filings, publications, and regulatory documentation as needed
Mentor junior scientists and contribute to a culture of scientific excellence and innovation
Perform other duties as assigned
Qualification
Required
Ph.D. in Molecular Biology, Biochemistry, Immunology, or related field with 2+ years of relevant industry or postdoctoral experience (or M.S. with 5+ years at Scientist level)
Hands-on experience with phage display platforms and antibody selection techniques
Strong understanding of antibody structure-function relationships and engineering strategies
Proficiency in molecular cloning, library construction, sequencing, and cell-based expression systems (bacterial, yeast, mammalian)
Experience with analytical tools such as ELISA, liquid handler automation, plate-based assays, flow cytometry, and affinity measurements (SPR, BLI)
Excellent problem-solving skills and ability to work independently and collaboratively
Highly proficient with Excel and molecular biology software (e.g. Geneious)
Preferred
Experience with next-generation sequencing (NGS) analysis of phage libraries
Familiarity with other display technologies (e.g., yeast, mammalian, p-display)
Knowledge of developability profiling (stability, post translational modifications, immunogenicity)
Prior experience in therapeutic antibody development or biologics pipeline
Experience with 3D modeling software
Benefits
401K
Medical insurance
Dental insurance
Vision insurance
Supplemental disability insurance plans
Flexible schedule
Life insurance
Flexible vacation
Sick time
Incentive stock option plan
Relocation assistance
Company
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Funding
Current Stage
Public CompanyTotal Funding
$898.94MKey Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M
Leadership Team
Recent News
2025-12-24
2025-12-04
2025-12-03
Company data provided by crunchbase